Biocryst Pharmaceuticals Inc SEC filings BCRX
Biocryst Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Mar 8, 2016. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| S-4/A | Filing | Dec 15, 2025 | — |
| S-4 | Registration for a merger or exchange | Nov 20, 2025 | — |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| S-3ASR | Automatic shelf registration | Feb 27, 2024 | — |
| S-8 | Employee stock plan registration | Nov 8, 2023 | — |
| S-8 | Employee stock plan registration | Jun 30, 2023 | — |
| S-8 | Employee stock plan registration | Aug 31, 2022 | — |
| S-8 | Employee stock plan registration | Jul 14, 2022 | — |
| S-8 | Employee stock plan registration | Sep 30, 2021 | — |
| 424B5 | Prospectus supplement | Aug 9, 2021 | — |
| S-8 | Employee stock plan registration | May 28, 2021 | — |
| S-8 | Employee stock plan registration | May 28, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 1, 2021 | — |
| S-8 | Employee stock plan registration | Aug 12, 2020 | — |
| S-8 | Employee stock plan registration | Jun 10, 2020 | — |
| S-8 | Employee stock plan registration | Jun 10, 2020 | — |
| S-8 | Employee stock plan registration | Jun 10, 2020 | — |
| 424B2 | Prospectus | May 29, 2020 | — |
| 424B5 | Prospectus supplement | May 27, 2020 | — |
| S-3 | Shelf registration | Apr 24, 2020 | — |
| 424B5 | Prospectus supplement | Nov 21, 2019 | — |
| 424B2 | Prospectus | Nov 14, 2019 | — |
| 424B5 | Prospectus supplement | Nov 12, 2019 | — |
| S-8 | Employee stock plan registration | Jun 4, 2019 | — |
| S-8 | Employee stock plan registration | Apr 29, 2019 | — |
| S-8 | Employee stock plan registration | Nov 9, 2018 | — |
| 424B2 | Prospectus | Aug 3, 2018 | — |
| 424B5 | Prospectus supplement | Aug 1, 2018 | — |
| S-3/A | Form s-3/a | Dec 4, 2017 | — |
| S-3 | Shelf registration | Nov 8, 2017 | — |
| 424B2 | Prospectus | Sep 14, 2017 | — |
| 424B5 | Prospectus supplement | Sep 11, 2017 | — |
| S-8 | Employee stock plan registration | May 31, 2017 | — |
| S-3 | Shelf registration | May 10, 2017 | — |
| 424B2 | Prospectus | Mar 10, 2017 | — |
| 424B5 | Prospectus supplement | Mar 8, 2017 | — |
| S-8 | Employee stock plan registration | May 23, 2016 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 882796
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.